POLR2M
DNA-directed RNA polymerase II subunit GRINL1A
Also known as: Gdown, Gdown1, GRINL1A, GRL1A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P0CAP2
- Gene
- POLR2M
- Ensembl
- ENSG00000255529
- Chromosome
- 15
- Canonical length
- 368 aa
- Protein class
- Predicted intracellular proteins, RNA polymerase related proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a subunit of a specific form of RNA polymerase II termed Pol II(G). The encoded protein may act as a negative regulator of transcriptional activation by the Mediator complex. Alternative splicing results in multiple transcript variants. There is a pseudogene for this gene on chromosome 4. Readthrough transcription between this gene and the neighboring upstream gene MYZAP (myocardial zonula adherens protein) is represented with GeneID 145781. [provided by RefSeq, Oct 2013]
Canonical amino-acid sequenceUniProt
368 residues, UniProt reviewed canonical sequence.
>P0CAP2|POLR2M
1 MCSLPRGFEP QAPEDLAQRS LVELREMLKR QERLLRNEKF ICKLPDKGKK IFDSFAKLKA
61 AIAECEEVRR KSELFNPVSL DCKLRQKAIA EVDVGTDKAQ NSDPILDTSS LVPGCSSVDN
121 IKSSQTSQNQ GLGRPTLEGD EETSEVEYTV NKGPASSNRD RVPPSSEASE HHPRHRVSSQ
181 AEDTSSSFDN LFIDRLQRIT IADQGEQQSE ENASTKNLTG LSSGTEKKPH YMEVLEMRAK
241 NPVPQLRKFK TNVLPFRQND SSSHCQKSGS PISSEERRRR DKQHLDDITA ARLLPLHHMP
301 TQLLSIEESL ALQKQQKQNY EEMQAKLAAQ KLAERLNIKM RSYNPEGESS GRYREVRDED
361 DDWSSDEFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POLR2M can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- tongue: 36 nTPM
- skeletal muscle: 34 nTPM
- endometrium: 32 nTPM
- blood vessel: 29 nTPM
- ovary: 28 nTPM
- heart muscle: 27 nTPM
Single-cell type
- oocytes: 65 nCPM
- endometrial glandular cells: 49 nCPM
- late primary spermatocytes: 48 nCPM
- epididymal clear cells: 47 nCPM
- kupffer cells: 43 nCPM
- smooth muscle cells: 39 nCPM
Immune cell
- basophil: 27 nTPM
- NK-cell: 25 nTPM
- naive CD4 T-cell: 20 nTPM
- T-reg: 19 nTPM
- gdT-cell: 18 nTPM
- naive B-cell: 17 nTPM
Brain region
- midbrain: 87 nTPM
- white matter: 85 nTPM
- basal ganglia: 77 nTPM
- spinal cord: 74 nTPM
- medulla oblongata: 74 nTPM
- thalamus: 74 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.73
- gnomAD pLI
- 0.03
- gnomAD missense Z
- -0.85
- DepMap mean gene effect
- -0.36
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- transcription elongation by RNA polymerase II
- maintenance of ER location
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Tuftelin/GRINL1A/MYZAP/CCD68
- DNA-directed RNA polymerase II subunit GRINL1
- Putative GRINL1B complex locus protein 2
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POLR2M as an antibody target. Whether an autoantibody or antibody against POLR2M could matter depends on whether native POLR2M is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POLR2M is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POLR2M as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...